REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-07-05. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
=== Expansion to Asia and Europe === Chick-fil-A CEO Andrew Cathy announced in March 2023 that it planned to open restaurants in Asia and Europe by 2026, and was set to expand to five overseas markets by 2030. The Wall Street Journal reported that it was seeking countries with "stable economies, dense populations, and a demand for chicken".
== Method == Depending on where the bone graft is needed, a different doctor may be requested to do the surgery. Doctors and physicians that perform bone graft procedures are commonly orthopedic surgeons, otolaryngology head and neck surgeon, neurosurgeons, craniofacial surgeons, oral and maxillofacial surgeons, podiatric surgeons and periodontists, dental surgeons, oral surgeons and implantologists.
== Flow control == There are various ways to control the fluid flow in the channels. They include changing the channel width and length, altering the wettability of the paper, diverting some fluid through a parallel channel, or changing the viscosity of the fluid. The flow in PADs can be turned off with dissolvable sugar bridges, Corona discharge treatment to alter a coating on the paper from a hydrophobic to hydrophilic state, or the use of an expandable polymer triggered by the flow to close the flow path.
Michael Howard Wigler (born September 3, 1947, in New York) is an American molecular biologist who has directed a laboratory at Cold Spring Harbor Laboratory since 1978 and is a member of the National Academy of Sciences. He is best known for developing methods to genetically engineer animal cells and his contributions to cancer, genomics and autism genetics.
Sources: en.wikipedia.org
An Oligopeptidase is an enzyme that cleaves peptides but not proteins. This property is due to its structure: the active site of this enzyme is located at the end of a narrow cavity which can only be reached by peptides.
The sequence in which the subshells are filled is given in most cases by the Aufbau principle, also known as the Madelung or Klechkovsky rule (after Erwin Madelung and Vsevolod Klechkovsky respectively). This rule was first observed empirically by Madelung, and Klechkovsky and later authors gave it theoretical justification. The shells overlap in energies, and the Madelung rule specifies the sequence of filling according to:
=== Wastewater treatment === Vacuum evaporators are used in a wide range of industrial sectors to treat industrial wastewater. It represents a clean, safe and very versatile technology with low management costs, which in most cases serves as a zero-discharge treatment system.
Ni(CO)4 ⇌ Ni + 4 CO This behavior is exploited in the Mond process for purifying nickel. The related nickel(0) complex bis(cyclooctadiene)nickel(0) is a useful catalyst in organonickel chemistry because the cyclooctadiene (or cod) ligands are easily displaced.
=== Iceland in 1986 === In 1986, at the age of 20, whilst at the University of Leeds, he crossed Iceland, together with three other students (Andrew Backhouse, David Brock and Shaun Fagan), from Seyðisfjörður in the east, through the interior to the north of the Vatnajökull ice fields, and then west to Reykjavík. The team encountered an 'ash storm', where storm force winds had whipped up fine black volcanic ash, and had to wear goggles and face masks to push on into the winds. In the rain shadow of the Vatnajökull, they ran out of water, then encountered a flash flood, as mud rushed down from the melting glaciers. They also had to survive on food contaminated with petrol that had leaked from their petrol stoves. This journey of 400 miles (640 km) raised £2,000 for the Royal Association for Disability and Rehabilitation. As part of the training for the walk across Iceland he ran the Leeds Marathon, in a time of 3 hours and 41 minutes. On the Icelandic trek, he came up with the idea of walking 6,000 miles (9,700 km), across Britain and America to raise money for Macmillan Cancer Support in Britain and hospice in America and Canada.
Sources: en.wikipedia.org
Clitoris: Made up of the root, glans and body and is usually retracted into a prepuce. Inside the clitoris of many non-human placentals is the baubellum, a small bone that possibly has origins in copulation. In horses and dogs, the clitoris is contained in clitoral fossa, which is a small pouch of tissue. Labia: A small, thin pair of lip-like structures that protect the vestibule. They are known as the labia vulvae in carnivorans and ungulates and as the labia minora in primates. The labia majora only exist in primates (including humans). Afrotherians do not have distinguishable labia. Vestibule/vulvar opening: In humans, other great apes, and some rodents, the vestibule is a flat and short external space that contains separate urethral and vaginal openings. In most other placentals, the urethra and vagina join as an internal vestibule (urogenital sinus), hence both urine and offspring exit through an orifice called the vulvar opening. During estrus, the clitoris of a mare (female horse) everts as the labia contracts by opening and closing. This is colloquially known as "winking". Throughout the menstrual cycle, some female primates' vulvar and anal regions will swell (sexual swelling) to attract a male, though the fundamental reason for this function is up for debate. The vulva of a spotted hyena has a large clitoris known as a pseudo-penis for copulating, giving birth and urinating, as well as fused labia (pseudo-scrotum). This can make it difficult to correctly sex the species.
c./ Exercise its right to self determination of independence, when the concerned, nation/nationality and people is convinced that the above rights are denied, abridged or abrogated."As such, one of the TGE's main aims was to establish a devolution of political power down to ethnic divisions, arguing that it was an essential move if the country wanted to lessen conflicts across ethnic lines, ensure a fairer distribution of resources across the country, and increase efficiency within the public sector. By 1994, the ethnically-based regions of Afar, Tigray, Somali, Amhara, Benishangul-Gumuz, Oromia, Harari, Gambela, and the Southern Nations, Nationalities, and Peoples Region (SNNPR), a diverse region inhabited by at least 40 different ethnic groups, were formally established. Addis Ababa, defined as a federal district, and later Dire Dawa were declared to be ethnically diverse chartered cities.
=== Xie === In contrast to the majority of other functional entities, xuè or xiě (血, "blood") is correlated with a physical form – the red liquid running in the blood vessels. Its concept is, nevertheless, defined by its functions: nourishing all parts and tissues of the body, safeguarding an adequate degree of moisture, and sustaining and soothing both consciousness and sleep. Typical symptoms of a lack of xiě (usually termed "blood vacuity" [血虚; xiě xū]) are described as: Pale-white or withered-yellow complexion, dizziness, flowery vision, palpitations, insomnia, numbness of the extremities; pale tongue; "fine" pulse.
Byzantine music is eclectically descended from early Christian plainsong, Jewish music, and a variety of ancient music; its exact connections to ancient Greek music remain uncertain. It included both sacred and secular traditions, but the latter is little known, whereas the former remains the central music of Eastern Orthodox liturgy into the 21st century. The empire's church music, known as Byzantine chant, was exclusively unaccompanied monodic vocal music, sung in Greek. From the 8th century, chant melodies were governed by the Oktōēchos framework, a set of eight modes—echos (ἦχος; lit. 'sound')—which each provide predetermined motivic formulae for composition. These formulae were chosen for proper text stress and occasionally for text painting, then collated through centonisation into hymns or psalms. Byzantine chant was central to the Byzantine Rite; the earliest music was not notated, including early monostrophic short hymns like the troparion. Proto-Ekphonetic notation (9th century onwards) marked simple recitation patterns. The neumatic Palaeo-Byzantine notation system emerged in the 10th century, and the Middle Byzantine "Round Notation" from the mid-12th century onwards is the first fully diastematic scheme. Several major forms developed alongside well-known composers: the long kontakion (5th century onwards), popularised by Romanos the Melodist; the also-extensive kanōn (late 7th century onwards), developed by Andrew of Crete; and the shorter sticheron (at least 8th century onwards), championed by Kassia.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.